Dr. Modesitt is the Director of the Gynecologic Oncology Division and the Co-Director of the High Risk Breast/Ovarian Cancer clinic at the University of Virginia. She is an Associate Professor and the Richard and Louise Crockett endowed Chair in Obstetrics and Gynecology. She completed her residency at the University of North Carolina and her fellowship at the M.D. Anderson Cancer Center. Dr. Modesitt served the Society of Gynecologic Oncology as Vice Chair of the Practice Survey Task force, Chair of the Candidate Task force and an Education Committee member. She was appointed to the Prolog Task force and Gynecologic Oncology Subcommittee for the American College of Obstetricians and Gynecologists. Dr. Modesitt is the UVA PI for the Gynecologic Oncology Group and is on the Safety Review and Developmental Therapeutics committees. Her research focuses on obesity related cancers, clinical trials and hereditary cancers.
Gynecologic oncologists discuss some of the most important research presented at the 2016 SGO Annual Meeting in San Diego. Ovarian cancer survivor and patient advocate Jocelyn Alfandre (pictured) was a featured speaker at the Annual Meeting.